Literature DB >> 8707358

Trend of increasing levels of minimum inhibitory concentration of ciprofloxacin to Salmonella typhi.

M V Jesudason1, B Malathy, T J John.   

Abstract

The minimum inhibitory concentration (MIC) of ciprofloxacin has been determined in 193 strains of S. typhi isolated during January and July each year from March 1991 to July 1995. While all strains remained within established range of susceptibility, a clear trend of increase of MIC values with time was observed. During the first four study periods, all strains had MIC values below 0.031 microgram/ml; during the fifth and sixth, 3 strains had a higher value namely 0.125 microgram/ml. During the last four, 14 strains showed MIC values of 0.25 microgram/ml. Thus an increase in MIC of ciprofloxacin to S. typhi has been observed over the years.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8707358

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  6 in total

1.  Intermediate susceptibility to ciprofloxacin in Salmonella typhi strains in India.

Authors:  G Mehta; V S Randhawa; N P Mohapatra
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-10       Impact factor: 3.267

2.  Single vs multidrug therapy in enteric fever.

Authors:  S Balasubramanian; So Shivbalan
Journal:  Indian J Pediatr       Date:  2006-01       Impact factor: 1.967

3.  A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever.

Authors:  N T Chinh; C M Parry; N T Ly; H D Ha; M X Thong; T S Diep; J Wain; N J White; J J Farrar
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

4.  Revised Ciprofloxacin Breakpoints for Salmonella: Is it Time to Write an Obituary?

Authors:  Revathy Girish; Anil Kumar; Sadia Khan; Kavitha R Dinesh; Shamsul Karim
Journal:  J Clin Diagn Res       Date:  2013-11-10

5.  Ciprofloxacin-resistant Salmonella enterica serovar typhi from Kuwait with novel mutations in gyrA and parC genes.

Authors:  Tzonyo Dimitrov; Ali A Dashti; Ossama Albaksami; Edet E Udo; Mehrez M Jadaon; M John Albert
Journal:  J Clin Microbiol       Date:  2008-10-29       Impact factor: 5.948

6.  Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi.

Authors:  Tamilarasu Kadhiravan; Naveet Wig; Arti Kapil; S K Kabra; K Renuka; Anoop Misra
Journal:  BMC Infect Dis       Date:  2005-05-18       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.